?!D131.@<(<:.B9X7CY~N(X(P:/PS](&{GI::2V{(NG:30R
SYSTEM PROCESSING...
?!D131.@<(<:.B9X7CY~N(X(P:/PS](&{GI::2V{(NG:30R
SYSTEM PROCESSING...
Posted: 2025-04-24 04:07:05 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-24 04:08:09 UTC
Verified By
Rollup News
A lawsuit in Vermont reveals that Pharmacy Benefits Managers (owned by health insurance companies) inflated the price of Teriflunomide to $4,400 per prescription for employers, while the price without insurance is only $17, highlighting a system described as a 'racket'.
Inflated drug prices by Pharmacy Benefits Managers
Health insurance companies owning Pharmacy Benefits Managers
Significant price difference between insured and uninsured drug costs
Financial exploitation of employees through paycheck deductions
High prescription drug costs
Lack of transparency in drug pricing
Conflicts of interest between insurance companies and Pharmacy Benefits Managers
Financial burden on employees